
    
      The purpose of this protocol is to evaluate the initial safety profile of the Fractyl System
      and its effect on participants with Type 2 Diabetes. This will be determined through the
      monitoring of adverse events and outcome measures including Mixed Meal Tolerance Test (MMTT).
    
  